RSS

Search results for tells

10
Vote

Plug-in Vehicles: Toyota Tells the Unvarnished Truth

Posted by expathos (#1) 681 days ago (http://seekingalpha.com)

John Petersen submits:Most investors know that Toyota Motors (TM) is

Read More | Discuss | Bury |

Stocks | plugin vehicles toyota tells unvarnished truth All

9
Vote

RBS tells clients to prepare for 'monster' money-printing: As the recovery starts to stall, bond strategists dust off Ben Bernanke's freshman Fed speech, which inlcudes this gem: "The U.S. government has a technology, called a printing press, that allows it to produce as many U.S. dollars as it wishes at essentially no cost."

Posted by expathos (#1) 694 days ago (http://seekingalpha.com)

RBS tells clients to prepare for 'monster' money-printing: As the rec

Read More | Discuss | Bury |

Stocks | rbs tells clients prepare monster moneyprinting recovery starts stall bond strategists dust ben bernankes freshman fed speech inlcudes gem the us government technology called printing press produce us dollars wishes essentially cost All

3
Vote

Small consumer electronics retailers are benefitting from the pain of their larger counterparts, Conn's (CONN) VC Bill Nylin tells investors at a retail conference. When the big boys cancel orders, vendors turn to CONN and its ilk offering hefty discounts, he says.

Posted by expathos (#1) 1218 days ago (http://seekingalpha.com)

Small consumer electronics retailers are benefitting from the pain of their larger counterparts, Conn's (CONN) VC Bill Nylin tells investors at a ret

Read More | Discuss | Bury |

Stocks | small consumer electronics retailers benefitting pain larger counterparts conns conn vc nylin tells investors retail conference big boys cancel orders vendors turn conn ilk offering hefty discounts says All

5
Vote

GlaxoSmithKline (GSK) CEO Witty, in a Bloomberg interview, tells the tale of new-pharma: "I would feel very comfortable if five or six years down the road half of our drug approvals came from products which weren’t originally discovered in a GSK laboratory."

Posted by expathos (#1) 1227 days ago (http://seekingalpha.com)

GlaxoSmithKline (GSK) CEO Witty, in a Bloomberg interview, tells the tale of new-pharma: "I would feel very comfortable if five or six years down the

Read More | Discuss | Bury |

Stocks | glaxosmithkline gsk ceo witty bloomberg interview tells tale newpharma i feel comfortable years road drug approvals products werenrsquot originally discovered gsk laboratory All

6
Vote

The roots of the crisis did not grow within the financial system alone, Henry Paulson tells the FT in a valedictory interview. Super-abundant savings from fast-growing emerging nations put downward pressure on yields and risk spreads everywhere, he says - implying future crises can only be avoided through global co-operation.

Posted by expathos (#1) 1234 days ago (http://seekingalpha.com)

The roots of the crisis did not grow within the financial system alone, Henry Paulson tells the FT in a valedictory interview. Super-abundant savings

Read More | Discuss | Bury |

Stocks | the roots crisis grow financial alone henry paulson tells ft valedictory interview superabundant savings fastgrowing emerging nations downward pressure yields risk spreads everywhere implying future crises avoided global cooperation All

« previous1 next »

Top Tags

buy escorts london escort london escorts

What is Pligg?

Pligg is an open source content management system that lets you easily create your own social network.

Top Users

Search results for tells

Plug-in Vehicles: Toyota Tells the Unvarnished Truth

Small consumer electronics retailers are benefitting from the pain of their larger counterparts, Conn's (CONN) VC Bill Nylin tells investors at a retail conference. When the big boys cancel orders, vendors turn to CONN and its ilk offering hefty discounts, he says.

GlaxoSmithKline (GSK) CEO Witty, in a Bloomberg interview, tells the tale of new-pharma: "I would feel very comfortable if five or six years down the road half of our drug approvals came from products which weren&rsquo;t originally discovered in a GSK laboratory."

GlaxoSmithKline (GSK) CEO Witty, in a Bloomberg interview, tells the tale of new-pharma: "I would feel very comfortable if five or six years down the road half of our drug approvals came from products which weren’t originally discovered in a GSK laboratory."